Innovative Partnership Targets Cancer-Causing 'Chaperones'

Cancer Research Technology (CRT) and The Institute of Cancer Research (ICR) announced a major research collaboration with AstraZeneca. The three partners will combine their expertise to discover and develop potential new anti-cancer drugs to target molecular 'chaperones' which support the growth of cancer cells.

read more

Deceases & treatment

• Specific immunotherapy (xenovaccinotherapy) for cancer
  • Melanoma
  • Kidney cancer
  • Colorectal cancer
  • Gastric cancer
  • Lung cancer
  • Prostate cancer
  • Astrocytoma
• T-cell vaccination (autovaccinotherapy) for autoimmune diseases
  • Multiple sclerosis
  • Rheumatoid arthritis
• Regenarative therapy
• Clinical application of stem celltransplantation
• Cell transplantation (CT) in treating severe neurological disorders (general information)
  • Spinal cord injury
  • Craniocerebral (brain) injury (coma)
  • Craniocerebral (brain) injury (long-term consequences)
  • Brain stroke
  • Cerebral palsy
  • 100 point scale for assessing neurological status of a cerebral palsy patient
• Hepatic diseases
• Osteomielitis
• Arthrosis

Site search